SECARNA Trademark

Trademark Overview


On Wednesday, January 19, 2022, a trademark application was filed for SECARNA with the United States Patent and Trademark Office. The USPTO has given the SECARNA trademark a serial number of 79340689. The federal status of this trademark filing is REGISTERED as of Tuesday, November 21, 2023. This trademark is owned by Secarna Pharmaceuticals GmbH & Co. KG. The SECARNA trademark is filed in the Computer & Software Services & Scientific Services, Personal and Legal & Social Services categories with the following description:

Granting of licenses to others in industrial property rights in the field of scientific research services in the field of biochemistry, except for the field of cell culture products, scientific research services in the field of nucleic acids and bioinformatics, in particular molecular-biological work methods, especially antisense technology, design of pharmaceutical active ingredients by means of the aforesaid methods and technologies, also using techniques of bioinformatics and development of pharmaceutical products by means of the aforesaid methods and technologies, also using techniques of bioinformatics, including carrying out associated test and diagnostic methods

Scientific research services in the field of biochemistry, except for the field of cell culture products; Scientific research services in the field of nucleic acids and bioinformatics, in particular molecular- biological work methods, especially antisense technology; design of pharmaceutical active ingredients by means of the aforesaid methods and technologies, also using techniques of bioinformatics; development of pharmaceutical products by means of the aforesaid methods and technologies, also using techniques of bioinformatics, including carrying out associated test and diagnostic methods; information technology (IT) consultancy services for the pharmaceutical and biotechnological industry; consultancy for others in the field of biochemistry and nucleic acids and bioinformatics, including antisense technology, with respect to the development of pharmaceutical products; safety and efficacy testing consultancy for others with respect to the evaluation of safety and efficacy of pharmac...
secarna

General Information


Serial Number79340689
Word MarkSECARNA
Filing DateWednesday, January 19, 2022
Status700 - REGISTERED
Status DateTuesday, November 21, 2023
Registration Number7220464
Registration DateTuesday, November 21, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 5, 2023

Trademark Statements


Goods and ServicesGranting of licenses to others in industrial property rights in the field of scientific research services in the field of biochemistry, except for the field of cell culture products, scientific research services in the field of nucleic acids and bioinformatics, in particular molecular-biological work methods, especially antisense technology, design of pharmaceutical active ingredients by means of the aforesaid methods and technologies, also using techniques of bioinformatics and development of pharmaceutical products by means of the aforesaid methods and technologies, also using techniques of bioinformatics, including carrying out associated test and diagnostic methods
Goods and ServicesScientific research services in the field of biochemistry, except for the field of cell culture products; Scientific research services in the field of nucleic acids and bioinformatics, in particular molecular- biological work methods, especially antisense technology; design of pharmaceutical active ingredients by means of the aforesaid methods and technologies, also using techniques of bioinformatics; development of pharmaceutical products by means of the aforesaid methods and technologies, also using techniques of bioinformatics, including carrying out associated test and diagnostic methods; information technology (IT) consultancy services for the pharmaceutical and biotechnological industry; consultancy for others in the field of biochemistry and nucleic acids and bioinformatics, including antisense technology, with respect to the development of pharmaceutical products; safety and efficacy testing consultancy for others with respect to the evaluation of safety and efficacy of pharmaceutics; evaluation of pharmaceutical products with respect to their safety and efficacy to assure compliance with industry standards

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, May 20, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class045 - Legal services; security services for the protection of property and individuals; personal and social services rendered by others to meet the needs of individuals.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, May 20, 2022
Primary Code045
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSecarna Pharmaceuticals GmbH & Co. KG
Party Type30 - Original Registrant
Legal Entity Type28 - NOT AVAILABLE
AddressDE

Party NameSecarna Pharmaceuticals GmbH & Co. KG
Party Type20 - Owner at Publication
Legal Entity Type28 - NOT AVAILABLE
AddressDE

Party NameSecarna Pharmaceuticals GmbH & Co. KG
Party Type10 - Original Applicant
Legal Entity Type28 - NOT AVAILABLE
AddressDE

Trademark Events


Event DateEvent Description
Monday, March 18, 2024FINAL DECISION TRANSACTION PROCESSED BY IB
Thursday, February 22, 2024FINAL DISPOSITION NOTICE SENT TO IB
Thursday, February 22, 2024FINAL DISPOSITION PROCESSED
Wednesday, February 21, 2024FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, November 21, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, November 21, 2023REGISTERED-PRINCIPAL REGISTER
Sunday, November 12, 2023NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Wednesday, October 25, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, October 25, 2023NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Tuesday, September 5, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 5, 2023PUBLISHED FOR OPPOSITION
Monday, September 4, 2023NOTIFICATION PROCESSED BY IB
Wednesday, August 16, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, August 16, 2023NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, August 16, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 25, 2023WITHDRAWN FROM PUB - OG REVIEW QUERY
Monday, July 10, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 14, 2023EXAMINER'S AMENDMENT ENTERED
Wednesday, June 14, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, June 14, 2023EXAMINERS AMENDMENT E-MAILED
Wednesday, June 14, 2023EXAMINERS AMENDMENT -WRITTEN
Tuesday, May 9, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, May 8, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, May 8, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, February 7, 2023REFUSAL PROCESSED BY IB
Tuesday, January 17, 2023NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, January 17, 2023REFUSAL PROCESSED BY MPU
Tuesday, January 17, 2023ASSIGNED TO EXAMINER
Monday, November 7, 2022NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sunday, November 6, 2022NON-FINAL ACTION WRITTEN
Friday, October 28, 2022ASSIGNED TO EXAMINER
Tuesday, May 24, 2022APPLICATION FILING RECEIPT MAILED
Friday, May 20, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, May 19, 2022SN ASSIGNED FOR SECT 66A APPL FROM IB